×
返回 Agenda
Session 3 : How to Leverage Innovative Tools to Accelerate Drug development for Asian Patients
Session Chair(s)
Hyouyoung Rhim, MD, MSC
Vice President, Yuhan Pharm inc., Korea, Republic of
Jing Ping Yeo, PHD, MBA
Vice President, Clinical Operations & Head, Asia Pacific Precision for Medicine, Precision for Medicine, Singapore
Speaker(s)
Meghana Chalasani, MHA
Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER, FDA, United States
Sergey Denisov
Sr. ML Engineer, Seltasquare, Korea, Republic of
Session 3 - 2
Henry Wu
Sr. Director, Regional Lead-China, HK and Eurasia, AstraZeneca R&D China, China
Session 3 - 3
Atsushi Ogawa
, ICON Japan K.K., Japan
Session 3 - 4
Fengyun (Vicky) Han
Senior Director, Head of Regulatory Policy for Asia Pacific, Johnson & Johnson Pte. Ltd., Singapore
Jing Ping Yeo, PHD, MBA
Vice President, Clinical Operations & Head, Asia Pacific Precision for Medicine, Precision for Medicine, Singapore